Longduoduo Company Limited (LDDD) Stock

About Longduoduo Company Limited

Longduoduo Company Limited, along with its associated entities, operates within the People's Republic of China, focusing on providing proactive health management and preventative medical services. The company's comprehensive suite of offerings includes health screenings, diverse treatment options, and specialized healthcare products, all aimed at reducing the likelihood of severe conditions such as myocardial infarction (heart attacks), cerebral infarction (strokes), hemiplegia (paralysis), and other cardiovascular and cerebrovascular diseases. These services are delivered through an extensive network of external collaborators, including independent healthcare providers, product vendors, and sales representatives. Additionally, Longduoduo features a range of advanced therapeutic interventions. These encompass meridian-regulating and consciousness-restoring techniques, a double blood purification process, immunological ozonated autohemotherapy, platelet-rich plasma therapy, relaxation techniques, vegetative nerve regulation, and microwave therapy. Established in 2020, the firm's primary operational base is located in Hohhot, China.

Longduoduo Company Limited is headquartered in CN.

Longduoduo Company Limited (LDDD) stock trades at $0.51 with a market capitalization of $15.31M. The stock is valued at a negative price-to-earnings (P/E) ratio of -43.59, reflecting a net loss over the last twelve months, price-to-book of 20.77, price-to-sales of 7.18. Over the past 52 weeks the stock has ranged between $0.51 and $4.99, and currently trades 89.8% below its 52-week high.

On profitability, Longduoduo Company Limited generates a return on equity (ROE) of -36.07% (negative, reflecting a net loss), return on capital employed of -52.71%, an operating margin of -20.17%, a net profit margin of -16.54%.

Official website: www.longduoduo.net